Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT04337931 |
| Consolidated Lead Sponsor | Apexigen America |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | TERMINATED |
| Registered Enrollment | 45 participants (ACTUAL) |
| Registered Start Date | 2019-06-12 |
| WhyStopped Classification | Safety / Toxicity / Adverse Events |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Hospital Universitari Vall d'Hebron | Barcelona, Spain | Open Hospital Dossier -> |
| Hospital Clínico San Carlos | Madrid, Spain | Open Hospital Dossier -> |
| Hospital Universitario 12 de Octubre | Madrid, Spain | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.